Contribution of renal function impairment to unexplained troponin T elevations in congestive heart failure

Nur Aksoy1, Orhan Ozer, Ibrahim Sari

  • 1Gaziantep University, School of Medicine, Department of Biochemistry, Gaziantep, Turkey. naksoy@gantep.edu.tr

Renal Failure
|May 23, 2009
PubMed

Insights

Impaired renal function, not just cardiac disease, contributes to elevated troponin T (TnT) levels in severe congestive heart failure (CHF) patients. This finding highlights the importance of kidney function in managing CHF and interpreting TnT results.

Area of Science:

  • Cardiology
  • Nephrology
  • Biochemistry

Background:

  • Severe congestive heart failure (CHF) patients often exhibit unexplained elevations in serum troponin T (TnT).
  • Cardiac TnT release due to underlying cardiac disease is the proposed cause.
  • This study investigates impaired renal function as an additional contributing factor.

Purpose of the Study:

  • To determine if impaired renal function contributes to elevated serum troponin T (TnT) levels in patients with severe congestive heart failure (CHF).

Main Methods:

  • Sixty-two patients with nonischemic CHF (NYHA class III-IV) and normal serum creatinine were studied.
  • Glomerular filtration rate (GFR) was calculated using the Cockcroft Gault equation.
  • Serum TnT levels were measured and correlated with clinical parameters.

Main Results:

  • Despite normal mean creatinine, mean GFR was low (56 mL/min).
  • Elevated TnT levels were found in 53% of patients.
  • Serum TnT levels were independently and negatively associated with GFR (p=0.005), more strongly than with cardiac function (LVEF).

Conclusions:

  • Impaired renal function (GFR) is a significant factor in elevated serum TnT levels in severe CHF patients.
  • Renal function's correlation with TnT was stronger than cardiac function (LVEF).
  • Impaired renal function likely causes troponin accumulation, explaining unexplained TnT elevations in severe CHF.
Abstract

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...